Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest vs COCP in Symptomatic Endometrioma
NCT07770594Completed
- Start
- Apr 2025
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Randomised, open-label trial of dienogest in endometrioma (2 arms). Primary endpoints: Change in Pain score at 3 months and Change in size of endometrioma at 3 months. Started Apr 2025; status: completed.
02
Drugs
dienogest
03
Conditions
endometrioma
Beyond the preview
Go deeper on NCT07770594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07770594.